{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:38:37Z","timestamp":1786523917525,"version":"build-2736575974"},"reference-count":16,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Home blood pressure monitoring (HBPM) is increasingly used in pregnancy, but evidence regarding its safety and clinical utility in women with hypertensive disorders of pregnancy (HDPs) remains limited. We aimed to compare maternal and fetal outcomes and healthcare use with HBPM versus clinic-based blood pressure monitoring. Methods: Cochrane, MEDLINE, Embase and PubMed were searched for randomized controlled trials published from January 1970 to December 2022; this review was undertaken to inform guideline development of hypertension in pregnancy in Australia and New Zealand. Two reviewers independently screened studies, extracted data and assessed risk of bias using RoB. Outcomes reported by at least two clinically comparable trials were pooled and heterogeneity was summarized using I2. Outcomes reported by a single trial are presented as individual study estimates and were not meta-analyzed. Certainty of evidence was assessed using GRADE. Results: Four randomized trials involving 3533 participants were included. HBPM was not associated with a statistically significant difference in preeclampsia, adverse maternal composite outcomes, severe hypertension (\u2265160\/110 mmHg), emergency delivery for hypertension, stillbirth, small-for-gestational-age birth or neonatal mortality. A single trial also found no statistically significant difference in preterm birth before 34 weeks. Serious fetal outcomes were uncommon and confidence intervals were wide. In one pilot trial, HBPM was associated with fewer antenatal visits and a longer duration of blood pressure monitoring. Conclusions: In structured care pathways with clinician oversight and predefined escalation protocols, HBPM was not associated with evidence of increased maternal or fetal risk and may be a useful adjunct to standard antenatal care. The small number of United Kingdom trials, sparse serious events and limited evidence in established or severe preeclampsia preclude conclusions of equivalence or definitive safety.<\/jats:p>","DOI":"10.3390\/jcm15166195","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:10:24Z","timestamp":1786374624000},"page":"6195","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Home Versus Clinic Blood Pressure Monitoring in Women with Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"15","author":[{"given":"Jolene Zhuo Lin","family":"Ng","sequence":"first","affiliation":[{"name":"Department of Renal Medicine, Liverpool Hospital, Sydney, NSW 2170, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Makris","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Liverpool Hospital, Sydney, NSW 2170, Australia"},{"name":"School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia"},{"name":"SWS Clinical School, University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Shanmugalingam","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Liverpool Hospital, Sydney, NSW 2170, Australia"},{"name":"School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia"},{"name":"SWS Clinical School, University of New South Wales, Sydney, NSW 2052, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","first-page":"7","article-title":"Hypertensive Disorders of Pregnancy","volume":"39","author":"Khedagi","year":"2021","journal-title":"Cardiol. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wu, P., Green, M., and Myers, J.E. (2023). Hypertensive disorders of pregnancy. BMJ, 381.","DOI":"10.1136\/bmj-2022-071653"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: A WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"ref_4","unstructured":"Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) (2023). SOMANZ Hypertension in Pregnancy Guideline 2023, SOMANZ."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1552-6909.2010.01172.x","article-title":"A historical overview of preeclampsia-eclampsia","volume":"39","author":"Bell","year":"2010","journal-title":"J. Obs. Gynecol. Neonatal Nurs."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/HJH.0000000000000673","article-title":"Home blood pressure monitoring: Australian Expert Consensus Statement","volume":"33","author":"Sharman","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Page, M.J., McKenzie, J.E., Bossuyt, P.M., Boutron, I., Hoffmann, T.C., Mulrow, C.D., Shamseer, L., Tetzlaff, J.M., Akl, E.A., and Brennan, S.E. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372.","DOI":"10.1136\/bmj.n71"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Beller, E.M., Glasziou, P.P., Altman, D.G., Hopewell, S., Bastian, H., Chalmers, I., G\u00f8tzsche, P.C., Lasserson, T., and Tovey, D. (2013). PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med., 10.","DOI":"10.1371\/journal.pmed.1001419"},{"key":"ref_10","unstructured":"Methods, C. (2023, November 12). Risk of Bias (RoB) Tool. Available online: https:\/\/methods.cochrane.org\/bias\/risk-bias-tool."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1001\/jama.2022.4712","article-title":"Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial","volume":"327","author":"Tucker","year":"2022","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1001\/jama.2022.4726","article-title":"BUMP 2 Investigators. Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals with Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial","volume":"327","author":"Chappell","year":"2022","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.preghy.2019.09.018","article-title":"A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial","volume":"18","author":"Pealing","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1471-0528.2000.tb11692.x","article-title":"Antenatal home blood pressure monitoring: A pilot randomised controlled trial","volume":"107","author":"Hewison","year":"2000","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Albadrani, M., Tobaiqi, M., and Al-Dubai, S. (2023). An evaluation of the efficacy and the safety of home blood pressure monitoring in the control of hypertensive disorders of pregnancy in both pre and postpartum periods: A systematic review and meta-analysis. BMC Pregnancy Childbirth, 23.","DOI":"10.1186\/s12884-023-05663-w"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yeh, P.T., Rhee, D.K., Kennedy, C.E., Zera, C.A., Lucido, B., Tun\u00e7alp, \u00d6., de Leon, R.G.P., and Narasimhan, M. (2022). Self-monitoring of blood pressure among women with hypertensive disorders of pregnancy: A systematic review. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-04751-7"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6195\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:21:12Z","timestamp":1786522872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":16,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166195"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166195","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}